CellFE launches T-Rest™, a first-in-class testing T cell kit for the manufacture of safer, more durable cell therapies. As part of the launch, CellFE has released an application note on its non-viral, ...
Use of immune checkpoint inhibitors as first line therapy for untreated, unresectable pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials. This is an ASCO ...
A team of immunologists at the University of Massachusetts Amherst has turned what we know about T-cells, one of the most important parts of the body's immune system, on its head, opening the door to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback